105 Matching Annotations
  1. May 2021
  2. Apr 2021
  3. Mar 2021
    1. A complicated and messy essay underlining the fact that people can figure out how to use technology in off-label ways to better humanity rather than sitting back on the intended uses of these tools.

      I definitely want to reference this in my presentation part of my workshop for "A Twitter of Our Own" for OERxDomains21.

    2. And it’s tempting for engineers to think decentralising the Web can be achieved with technology. But really, it’s people who will make it happen. Rather than staying put in our little filter bubbles, we can burst out of them — and be radically sociable, delinquent, and make a scene.

      off label uses of technology are important

      I'm reminded of how Kicks Condor has appreciated my "people work" in the past.

  4. Jan 2021
    1. What Are White-Label Restaurant Apps? And When Does It Make Sense to Use One

      Short on time but want to join the food delivery niche, quickly improve your online visibility, and grow your customer base? There’s a solution ― a white-label restaurant app. Can white-label software bring big results for your restaurant? It may or may not. Much depends on your business processes, application requirements, and budget. Dive in to learn more.

  5. Mar 2020
    1. l-thyroxine was added in the dose of 100 microm daily for 4 weeks.

      This is the same dosage that another study found to be indiscernible from placebo. I suspect a couple things are at play.

      The first is that these are treatment-resistant patients, meaning that we already know they are not susceptible to placebo; given that we are effectively comparing combination therapy to SSRIs alone, this means that the SSRI only stage is not experiencing placebo, thus making the therapeutic effect visible by comparison (retrospective comparison, given that there is no control group).

      The second is that this is combination therapy. It seems likely that thyroxine is more effective when combined with SSRIs.

      Note that this study uses much lower doses than similar studies I've seen, yet had similar results in terms of efficacy rate (roughly 50% responders). I'm not currently certain how the magnitude of effects compares with those studies. Namely, comparing with Pfeiffer et al (350 mcg), Rudas et al (235 mcg) and Bauer et al (482 mcg), and also Bauer et al from 2016 (300 mcg)

  6. Sep 2019
  7. Aug 2019
  8. Oct 2017
  9. Apr 2017
  10. Mar 2017
  11. Feb 2017
  12. Nov 2016
  13. Oct 2016